New plague test could speed up diagnosis in remote congo
NCT ID NCT07174648
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new rapid diagnostic test for plague in the Ituri province of DR Congo. Researchers will collect samples like blood, saliva, and bubo fluid from 300 people with suspected plague to see how well the new test works compared to standard lab methods. The goal is to help doctors diagnose plague faster and learn more about how the disease spreads.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Duplex F1V rapid diagnostic test (RDT)
- What this could lead to
- If successful, this test could help doctors diagnose plague faster and more easily in remote areas, potentially saving lives by enabling quicker treatment.
- What could go wrong
- This is an early field evaluation with only 300 participants, so the test may not perform as well in real-world conditions. It is not a treatment study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
People (\> 5 years of age), living within Rethy, Logo and Aru health zones
- Ages
-
5 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All participants (aged ≥5 year old) within Rethy, Logo and Aru health zones, presenting with possible symptoms of bubonic and/or pneumonic plague according to WHO definition * Willing to provide voluntary consent (or voluntary assent and parental consent in case of minors. Exclusion Criteria: * Participants not eligible, able, or willing to undergo study procedures * Children \<5 years of age * Participants on antibiotic treatment ≥48h prior to recruitment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bubonic; plague, skin are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre De Recherche en Maladies Tropicales De L'ituri
Rethy, Democratic Republic of the Congo
More trials for these conditions
Other studies related to the condition(s) this trial covers.